Marta Ferrer
www.cun.es
0000-0001-8495-1302
Universidad de Navarra
128 papers found
Refreshing results…
Unveiling chronic spontaneous urticaria pathophysiology through systems biology
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
Role of nanostructures in allergy: diagnostics, treatments,and safety
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
Improvement of the Elevated Tryptase Criterion to Discriminate IgE- From Non–IgE-Mediated Allergic Reactions:
Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis
Biologics in chronic urticaria
Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
Adjuvants for allergy immunotherapeutics
Adjuvants for allergy immunotherapeutics.
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Angio-oedema without hives, IgE and omalizumab.
Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion
Allergy rhinitis: similarities and differences between children and adults
Evaluation of the clinical utility of the Spanish version of urticaria activity score and urticaria activity score-7 for chronic urticaria
Predicting return of chronic idiopathic urticaria symptoms following omalizumab treatment discontinuation: Exploratory analysis of phase III data
Missing publications? Search for publications with a matching author name.